Published in Cancer Weekly, April 26th, 2005
"The demonstration of the PAX8-PPARgamma fusion oncogene in a subset of follicular thyroid tumors provides a new and promising starting point to dissect the molecular genetic events involved in the development of this tumor form," scientists in the United States reported.
"In the present study, we compared the gene expression profiles of FTCs bearing a PAX8-PPAR7 fusion against FTCs that lack this fusion. Using unsupervised clustering and multidimensional sealing analyses, we show that FTCs possessing a PAX8-wPPARgamma fusion...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.